The classic azole antifungal drugs affect steroidogenic activity in a human term placenta model

Line Mathiesen, Lisa Hoyng Alstrup, Stine Buchholdt, Diana Petra Sjöberg-Guttesen, Ida Elise Mølgaard Hammer, R. Koch, Anna Christine Drachmann Kragh, Dea Sandal, Isabella Dubiel Stæhr, Caroline Agerlin Ødum, Malene Louise Johannsen, Flemming Steen Jørgensen, Christian Janfelt, Lisbeth E. Knudsen, Bjarne Styrishave
In: Pharmacological Research · 2025 · vol. 220 , pp. 107940 · doi:10.1016/j.phrs.2025.107940 · PMID:40886781 · W4413847367
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-10 ⓘ

Azole antifungal drugs permeated the placenta and inhibited placental aromatase activity, leading to altered androgen and estrone levels without affecting steroidogenic enzyme gene expression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

During pregnancy there is an increased risk of vulvovaginal candidiasis that if left untreated is associated with pregnancy complications. First choice of treatment are over-the-counter azole antifungal drugs (AADs): miconazole, and clotrimazole, or prescription drug: fluconazole, which are suspected endocrine disruptive compounds. To investigate foetal exposure and endocrine disrupting effects of AADs on the human placenta, we added R-miconazole, S-miconazole, clotrimazole and fluconazole to the maternal reservoir of a dually recirculating ex vivo human term placental perfusion model. After three hours perfusion, AADs and steroids in perfusion media and placental tissue were quantified by LC-MS/MS, and real-time qPCR was performed to investigate gene expression of relevant steroidogenic enzymes in the placenta. We also investigated the distribution of AADs in the placenta using MS Imaging, and modelled interactions between AADs and the highly active steroidogenic enzyme, CYP19A1 (aromatase). Both enantiomers of miconazole, clotrimazole and fluconazole permeated the placenta reaching equilibrium between maternal and foetal compartments within 90 min. Miconazole and clotrimazole accumulated in placental tissue, whereas fluconazole reached a foetal compartment concentration of 50 % of added dose. We observed increased levels of androgens and decreased levels of oestrone in maternal and foetal perfusates, indicating inhibitory effects on placental aromatase activity, with the imidazoles, miconazole and clotrimazole, being more potent than the triazole fluconazole. MS imaging and molecular docking supported these findings. No significant changes in gene expression were observed for CYP11 A1, CYP19A1, and 3β-HSD after exposure to AADs. Overall, our study indicates that AADs affect placental endocrinology by inhibiting aromatase function.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (58)

SciLite annotations

chemicals 22
azole azole miconazole clotrimazole fluconazole miconazole miconazole clotrimazole fluconazole steroid miconazole clotrimazole fluconazole miconazole clotrimazole fluconazole androgen estrone imidazoles miconazole triazole fluconazole
organisms 3
human human human

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK